TRINITY MEDICAL GROUP INC
10QSB, EX-4.7, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: TRINITY MEDICAL GROUP INC, 10QSB, 2000-11-14
Next: TRINITY MEDICAL GROUP INC, 10QSB, EX-27.1, 2000-11-14



                              [TRINITY LETTERHEAD]


                                                                November 6, 2000

To:      Subscribers of the June 2000 Private
         Placement of Securities of Trinity Medical Group USA, Inc.


         We are  pleased  to inform  you that on October  20,  2000,  we filed a
registration  statement on Form SB-2 with the Securities and Exchange Commission
to register the shares of common stock of the Company  that you  subscribed  for
through our June 2000 private placement.  The number of shares registered on the
registration  statement  reflects  the number of shares  underlying  each common
stock unit,  with each common  stock unit  consisting  of 1,000 shares of common
stock,  par value $.001 (the "Common  Stock"),  and a warrant to purchase  1,000
shares  of  Common  Stock,  with an  exercise  price of  $4.00  per  share  (the
"Warrant").

         You  will  note  that  the   Private   Placement   Memorandum   ("PPM")
inadvertently  referred to preferred  series A stock rather than to common stock
units.  Instead of  referring  to each unit of  preferred  series A stock  being
ultimately  convertible into 1,000 shares of Common Stock and a Warrant, the PPM
should  have  referred to common  stock  units  because the Company did not have
preferred shares authorized. Since there is no change in the amount of shares of
Common Stock to be issued,  you are entitled to 1,000 shares of Common Stock and
a Warrant for each unit you purchased.

         Our records show that we have not issued you the shares of Common Stock
and a Warrant underlying the common stock units. Accordingly, we have instructed
our transfer agent to issue a stock  certificate for your shares of Common Stock
and we will deliver the stock  certificate  and your Warrant to you upon receipt
from the transfer agent.

         Please  acknowledge your agreement with the foregoing by signing in the
space below and faxing a signed copy to the undersigned at 415-256-1994 as soon
as possible, so we may expedite the issuance of your Common Stock and Warrant.

         We thank you for your continued support of the Company. If you have any
questions  regarding the shares of Common Stock to be issued to you, please feel
free to call me.

                                              Very truly yours,

                                              Trinity Medical Group USA, Inc.


                                              By: /s/ James S. Namnath
                                                 ---------------------------
                                                 Name: James S. Namnath
                                                 Title: Chief Executive Officer

Agreed and Acknowledged:

By:
   --------------------------
Name:
     ------------------------


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission